Yahoo
Irish EUR

Glanbia plc (GL9.IR)

19.15 +0.07 (+0.37%)
As of 12:37:57 PM GMT+1. Market Open.
Chart Range Bar
Loading chart for GL9.IR
  • Previous Close 19.08
  • Open 19.11
  • Bid 19.16 x 2908600
  • Ask 19.19 x 6209100
  • Day's Range 18.91 - 19.38
  • 52 Week Range 13.98 - 25.10
  • Volume 38,522
  • Avg. Volume 435,414
  • Market Cap (intraday) 4.628B
  • Beta (5Y Monthly) 0.51
  • PE Ratio (TTM) 23.07
  • EPS (TTM) 0.83
  • Earnings Date Aug 6, 2026
  • Forward Dividend & Yield 0.45 (2.32%)
  • Ex-Dividend Date Aug 20, 2026
  • 1y Target Est 24.06

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing business; property and land dealing business; property leasing; provision of business services and management solutions; and bioactive solutions. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, think!, Amazing Grass brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.

www.glanbia.com

4,963

Full Time Employees

January 03

Fiscal Year Ends

Packaged Foods

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/9/2026, which may include dividends or other distributions. Benchmark is ISEQ All Share (^ISEQ) .

YTD Return

GL9.IR
34.65%
ISEQ All Share (^ISEQ)
6.82%

1-Year Return

GL9.IR
39.04%
ISEQ All Share (^ISEQ)
19.39%

3-Year Return

GL9.IR
37.10%
ISEQ All Share (^ISEQ)
71.68%

5-Year Return

GL9.IR
63.45%
ISEQ All Share (^ISEQ)
66.51%

Analyst Insights

View More

Analyst Price Targets

20.07
24.06 Average
19.15 Current
27.62 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 9/22/2026
  • Market Cap

    4.82B

  • Enterprise Value

    5.55B

  • Trailing P/E

    23.59

  • Forward P/E

    13.64

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.37

  • Price/Book (mrq)

    2.92

  • Enterprise Value/Revenue

    1.55

  • Enterprise Value/EBITDA

    14.21

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.80%

  • Return on Assets (ttm)

    6.22%

  • Return on Equity (ttm)

    12.05%

  • Revenue (ttm)

    4.1B

  • Net Income Avi to Common (ttm)

    237.7M

  • Diluted EPS (ttm)

    0.83

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    375.7M

  • Total Debt/Equity (mrq)

    63.69%

  • Levered Free Cash Flow (ttm)

    335.58M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: